<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00954811</url>
  </required_header>
  <id_info>
    <org_study_id>recombinant LH 1505</org_study_id>
    <nct_id>NCT00954811</nct_id>
  </id_info>
  <brief_title>Luteal Supplementation With Rec-LH After GnRH-agonist Triggering in In Vitro (IVF)</brief_title>
  <official_title>A Phase IV Study on the Effect of Luteal Supplementation With Rec-LH on the Pregnancy Rate After Ovulation Triggering With GnRH-agonist Instead of HCG in IVF Protocol;Proof of Concept</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitair Ziekenhuis Brussel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Merck Serono International SA</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Universitair Ziekenhuis Brussel</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Our aim is to access whether we can achieve equivalent pregnancy rates by the addition of six
      doses of luteal support with recLH after agonist triggering for IVF cycles in the absence of
      OHSS.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Whether pregnancy outcome after GnRH-agonist triggering could be improved by adding luteal
      recLH support plus progesterone, compared to that observed after ovulation triggering with
      HCG in GnRH antagonist stimulated cycles.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2005</start_date>
  <completion_date type="Anticipated">December 2010</completion_date>
  <primary_completion_date type="Anticipated">January 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>pregnancy occurrence, pregnancy loss</measure>
    <time_frame>14 days after OPU</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>hormone levels, OHSS, endometrium</measure>
    <time_frame>14 days after oocyte pick up</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Pregnancy</condition>
  <condition>Pregnancy Loss</condition>
  <arm_group>
    <arm_group_label>HCG for ovulation triggering and luteal progesterone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>conventional triggering with HCG and conventional luteal support with progesterone</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Agonist triggering and rec-LH luteal support plus progesterone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>new method of triggering with GnRH-agonist and proof of concept intervention with novel way of luteal support with rec-LH plus the usual co-treatment with progesterone</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>300IU rec-LH</intervention_name>
    <description>luteal alternate doses</description>
    <arm_group_label>Agonist triggering and rec-LH luteal support plus progesterone</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>progesterone 600mg</intervention_name>
    <description>luteal support</description>
    <arm_group_label>HCG for ovulation triggering and luteal progesterone</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  &lt; 36years,

          -  single blastocystET,

          -  FSH &lt; 12

        Exclusion Criteria:

          -  endometriosis,

          -  3 and 4,

          -  pco,

          -  frozen sperm
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>36 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paul Devroey</last_name>
    <role>Study Chair</role>
    <affiliation>Professor or OB-GYN</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Evangelos Papanikolaou, PhD</last_name>
    <email>drvagpapanikolaou@yahoo.gr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centre for Reproductive Medicine, UZ Brussel</name>
      <address>
        <city>Brussels</city>
        <state>Jette</state>
        <zip>1090</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Evangelos Papanikolaou, MD,PhD</last_name>
      <phone>0032 2 4776606</phone>
      <email>drvagpapanikolaou@yahoo.gr</email>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <link>
    <url>http://www.brusselsivf.be/default.aspx?lang=EN</url>
    <description>main web page of the centre for reproductive medicine in UZ Brussels</description>
  </link>
  <verification_date>August 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 6, 2009</study_first_submitted>
  <study_first_submitted_qc>August 6, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 7, 2009</study_first_posted>
  <last_update_submitted>January 7, 2010</last_update_submitted>
  <last_update_submitted_qc>January 7, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 8, 2010</last_update_posted>
  <responsible_party>
    <name_title>Dr Papanikolaou Evangelos</name_title>
    <organization>Centre for Reproductive Medicine,UZ Brussel</organization>
  </responsible_party>
  <keyword>pregnancy</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Progesterone</mesh_term>
    <mesh_term>Deslorelin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

